Nasdaq Glsi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq glsi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Glsi Today - Breaking & Trending Today

Insider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases 2,500 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel bought 2,500 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were purchased at an average price of $19.98 per share, for a total transaction of $49,950.00. Following the purchase, the chief executive officer now owns 5,347,777 shares in […] ....

Snehal Patel , Northern Trust Corp , Securities Exchange Commission , Capital Partners , Greenwich Lifesciences Inc , Susquehanna International Group , Greenwich Lifesciences , Get Free Report , Exchange Commission , Lifesciences Trading Down , International Group , Street Group , Greenwich Lifesciences Daily , Nasdaq Glsi , Insider Trading , Nsider Trades ,

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Purchases 12,700 Shares

Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the stock in a transaction on Thursday, February 15th. The stock was bought at an average price of $11.07 per share, with a total value of $140,589.00. Following the completion of the acquisition, the chief executive officer now directly owns […] ....

Snehal Patel , Capital Partners , Citigroup Inc , Greenwich Lifesciences Inc , Walleye Capital , Greenwich Lifesciences Company Profile , Goldman Sachs Group Inc , Greenwich Lifesciences , Get Free Report , Goldman Sachs Group , Greenwich Lifesciences Daily , Nasdaq Glsi , Insider Trading , Nsider Trades ,

Insider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires 12,700 Shares of Stock

Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were purchased at an average cost of $11.07 per share, for a total transaction of $140,589.00. Following the acquisition, the chief executive officer now directly owns 5,325,377 shares […] ....

United States , Snehal Patel , America Corp , Greenwich Lifesciences Company Profile , Goldman Sachs Group Inc , Walleye Capital , Greenwich Lifesciences Inc , Cubist Systematic Strategies , Citadel Advisors , Securities Exchange Commission , Greenwich Lifesciences , Get Free Report , Exchange Commission , Sachs Group , Systematic Strategies , Greenwich Lifesciences Daily , Nasdaq Glsi , Insider Trading , Nsider Trades ,

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 12.7% in June

Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) was the target of a large decline in short interest in June. As of June 30th, there was short interest totalling 195,500 shares, a decline of 12.7% from the June 15th total of 224,000 shares. Approximately 3.3% of the company’s stock are short sold. Based on an […] ....

United States , Vanguard Group Inc , Greenwich Lifesciences Inc , America Corp , Millennium Management , Renaissance Technologies , Greenwich Lifesciences , Get Free Report , Street Corp , Greenwich Lifesciences Daily , Nasdaq Glsi ,